Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
Approved P.L.2026, c.40.
Email me when A 4852 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track A 4852. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill lets licensed health‑care providers issue Schedule II drug prescriptions through real‑time video or approved asynchronous telehealth, eliminating the usual in‑person exam requirement. Patients must be informed of the provider’s credentials, may request a physician, and providers must follow the same standard of care as in‑person visits. The change aims to expand access while preserving safety and oversight.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about A 4852
3 free questions a day, no accountHearings
- General Assembly — SessionGeneral Assembly · Jun 30, 2026
- State and Local Government — MeetingState and Local Government · Jun 23, 2026
History
- Introduced, Referred to Assembly Health Committee
Sponsors
- Andrea Katz (D) · sponsor
- Katz, Andrea
- Kearney, Vincent M.
- Sweeney, Marisa
- Tully, Chris
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when A 4852 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track A 4852 freeOr ask your AI assistant about A 4852 directly:
Add to Claude, ChatGPT or Cursor